Breast Cancer
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony sti
Extranuclear expression of hormone receptors in primary breast cancer
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
Editorial
Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
gastrointestinal tumors
Alternative clinical end points in rectal cancer—are we getting closer?
First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer
gynecologic tumors
CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study
Hematologic Malignancies
Mast cells in Waldenstrom\'s macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling
Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin\'s lymphoma: a population-based study
A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin\'s disease patients
Lung cancer
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95–01)
phase I and pharmacokinetics
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
Reviews
Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
Sarcoma
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing\'s sarcoma family of tumours
Supportive care
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
